Meet Minerva in the middle. At the intersection of technology and gynecology. Experience modern care that preserves your uterus, while treating AUB.
“This feels just right”
Minerva's minimally invasive devices help physicians target the causes of AUB, rather than medicate the symptoms or remove the organ altogether. Each treatment is minimally invasive and, in many cases, is performed in the physician’s office.
Engineered to elevate the experience for you and your physician. Designed to improve upon all those devices that came before.
Endometrial ablation is a one-time treatment that is effective at reducing or eliminating bleeding and clots due to AUB-E. The treatment involves a minimally invasive method of removing the uterine lining. This is the layer that sheds during your period.
Designed by the same team that developed NovaSure in the 1990s, Minerva ES was judged to be statistically significantly more effective1, in 2015, when the FDA compared Minerva ES to a group of product treatments that included NovaSure® and 4 other previously FDA approved products.
The soft silicone tip of Minerva ES changes the entire experience.
Minerva ES
NovaSure
Soft, silicone tip
NovaSure®
Metalized mesh tip
Minerva ES uses heated plasma energy that is fully contained within the silicon tip, rather than the NovaSure electrified metalized mesh that is in direct contact with the uterus.
Minerva ES
NovaSure
A soft, silicone membrane contains plasma that heats your uterine tissue.
NovaSure®
Higher powered electricity sent through exposed metallized mesh comes in direct contact with your uterine tissue.
NovaSure requires the removal of moisture from the uterine cavity due to the exposed, electrified metallized mesh.
The soft silicone membrane on Minerva ES allows for the moisture to remain so it can flow throughout the uterine cavity, reaching areas that do not come in contact with the membrane, for complete coverage.
The heat and remaining moisture remove the top layer of the endometrium, which is the lining of the uterine cavity. This takes just 120 seconds.
At the end of two minutes, the device is closed and your doctor gently removes it from the uterus. The silicone covering ensures removal without sticking.
Thank you, Engineering.
PlasmaSense technology eliminates the need for uterine tissue to come in direct contact with the Minerva ES device. The NovaSure device requires direct tissue contact, which is created by using a vacuum to pull the uterine walls directly onto the device. This vacuum also removes the moisture that builds up in the uterus during the ablation cycle in order to ensure continued direct contact between the uterine wall and the device. With Minerva ES, the moisture remains and helps ensure all uterine tissue is thermally ablated from either the moisture itself or from being in contact with the silicone array.
(from separate clinical trials for FDA approval)
Genesys HTA is an alternative endometrial ablation system to Minerva ES. It is designed to help ensure that a woman with an atypically shaped uterus has access to an ablation.
Instead of plasma contained in a silicone tip, HTA uses heated saline that circulates throughout the uterine cavity for ten minutes. During the treatment, your physician maintains continuous visualization of your uterus, while the saline ensures complete coverage of all endometrial tissue.
While Minerva ES delivers the best clinical results of all endometrial ablation treatments available today1, the Genesys HTA results can be the difference between AUB and a normal, regular period.
For many women, that’s just right.
Symphion removes fibroids and polyps through the vagina and cervical canal, without the need for incisions. After slightly dilating the cervical canal, a thin tube with a tiny camera at the end is inserted through the cervix and into the uterus.
A smaller wand-like device is then inserted through the tube and into the uterine cavity. At the tip is a window that enables the removal of fibroids and polyps without using blades.
Tissue from the uterine cavity is continuously removed via the window. When all tissue has been removed, the wand and tube are removed from the uterus.
Symphion uses RF plasma technology and suction to safely remove fibroid tissue from the uterine cavity. This technology eliminates the need for blades, which cut fibroid tissue into small pieces.
*for more on this download the patient guide below
Resectr is a small device that can be used to remove polyps in the exam room at your doctor’s office. This handheld device replaces old-fashioned tools like forceps.
With Resectr, your physician quickly removes polyps without pulling or tugging them out.
Which is nice, right?
After slightly dilating your cervix, a hysteroscope (a thin tube with a miniature camera at the tip) is inserted into your uterus. This allows your physician to see the uterine cavity. Then, Resectr is inserted into the channel of the hysteroscope and into your uterus.
Resectr has a window at the tip. In the window is a tiny blade. The device window is placed on the polyp, and the internal blade and suction remove the polyp from your uterus.
Polyps can be just as disruptive to your life as fibroids, and they have the potential to become cancerous.5 So, if you are experiencing symptoms of polyps, ask your gynecologist for a diagnostic hysteroscopy.
A consultation with a gynecologist who understands AUB is what you need and deserve.
Locate an AUB expertYou have the final say in what device is used during a treatment for you. But not all physicians offer all available devices, so you may not be informed of all available treatment options at one medical practice.
After receiving a diagnosis, ask your physician about the available treatment options and which they offer. You may find that you need to get a second opinion from a physician who offers a variety of treatment options. Visit our physician locator to find a gynecologist near you that offers Minerva treatment options.
Yes, but that doesn’t mean that that all treatments perform the same way or deliver the same results. For example, if one device receives FDA clearance and then two years later a new device receives clearance that treats the same condition but is more effective, the FDA does not remove the older device from the market. So, it comes down to the patient knowing that the doctor to whom she is entrusting her care is using treatments from a company that is best-in-class, and is using the right device for her specific situation.
Symphion is a system used by physicians to perform diagnostic hysteroscopies, and to remove uterine tissue like polyps (polypectomy) and fibroids (myomectomy). The uterus is accessed via the vagina and cervix. This eliminates the need for incisions or the removal of the uterus (hysterectomy).
The Symphion System enables clear visualization of your uterine cavity and does not use mechanical blades to cut fibroids into pieces for removal. It uses plasma technology and the unique design of the device tip to simultaneously cut and suction out the fibroid tissue. For the physician, the ability to see clearly and remove all fibroid tissue quickly is very important to protect your health.
Some women have mild cramping. Rarely do women need anything but over the counter pain medicine. Most women are back to normal activities within a few days.
Removing symptomatic fibroids may improve your experience with your period and your overall health and quality of life. If you are experiencing difficulties getting pregnant or maintaining a pregnancy, and it’s determined that you have fibroids, your chances of getting pregnant and maintaining the pregnancy may increase after fibroid removal, but there are many factors that may influence conception.
Minerva ES is a device that physicians use to perform an endometrial ablation. Endometrial ablation is a method of removing the endometrial layer of tissue in the uterine cavity to treat AUB.
Clinical studies with the Minerva ES resulted in significant safety and effectiveness results for endometrial ablation. These results are published and show improvement compared to older models and designs*, as Minerva ES was designed to improve upon pre-existing ablation devices in these key ways:
*Laberge P, Garza-Leal J, Fortin C, Grainger D, Johns DA, Adkins RT, Presthus J, Basinski C, Swarup M, Gimpelson R, Leyland N, Thiel J, Harris M, Burnett PE, Ray GF. A Randomized Controlled Multicenter US Food and Drug Administration Trial of the Safety and Efficacy of the Minerva Endometrial Ablation System: One-Year Follow-Up Results. J Minim Invasive Gynecol. 2017 Jan 1;24(1):124-132.
Every woman is different, but at 1 year post-Minerva ES, 72%* of women had their period completely eliminated.
In the first year after Minerva ES treatment, many women experience a few cycles, but they are typically light enough to be handled with liners and last only a few days.
93%* of women who had the Minerva treatment had their periods reduced to a bleeding level of normal or less at 1 year.
At 1 year post-treatment with the NovaSure procedure, periods were completely eliminated in just 36%** of women.
After Minerva ES, most women resume normal activities within a day or two. You may experience some cramping, mild pain or nausea. You may also experience some discharge for a few days to a few weeks. Your gynecologist will review this with you so that you know what to expect. Be certain to follow the guidance of your gynecologist for all post-treatment care plans.
*Laberge P, Garza-Leal J, Fortin C, Grainger D, Johns DA, Adkins RT, Presthus J, Basinski C, Swarup M, Gimpelson R, Leyland N, Thiel J, Harris M, Burnett PE, Ray GF. A Randomized Controlled Multicenter US Food and Drug Administration Trial of the Safety and Efficacy of the Minerva Endometrial Ablation System: One-Year Follow-Up Results. J Minim Invasive Gynecol. 2017 Jan 1;24(1):124-132.
**NovaSure Advanced Impedance Controlled Endometrial Ablation System. Instructions For Use and Controller Operator’s Manual. Available at: https://www.hologic.com. Accessed February 04, 2019. (Not based on a head-to-head study).
There are no long-term side effects associated with reducing or removing the uterine lining.
With all surgical procedures, including endometrial ablation, serious injury or death can occur.
The following adverse events could occur or have been reported in association with the use of other endometrial ablation systems and may occur with the Minerva System:
Genesys HTA is an endometrial ablation device that uses heated saline to remove the endometrial lining for the treatment of AUB. This ablation device enables the physician to see your uterine cavity throughout the treatment, and, as with Minerva ES, there is no vacuum used or exposed heating element in your uterus. Instead, this treatment involves only circulating heated saline.
This device may be right for women who wish to lighten their periods and aren’t looking to end them altogether (amenorrhea). Genesys HTA is special for another reason: it is designed for unusually shaped uterine cavities, so this endometrial ablation option may be available to more women. Typically, treatments take approximately 10 minutes.
Every woman is different, but most women experience fewer and lighter cycles after Genesys HTA. Periods are often light enough for just liners and last only a few days.
After Genesys HTA, most women resume normal activities within a day or two. You may experience some cramping, mild pain, or nausea. You may also experience some discharge for a few days to a few weeks. Your gynecologist will walk you through what to expect. Be certain to follow the guidance of your gynecologist for all post-treatment care plans.
Except for reducing or eliminating periods, there are no long-term side effects associated with the reducing or removal of the uterine lining.
As with any surgical procedure, there are potential risks associated with endometrial ablation. Endometrial ablation is not a sterilization procedure. And it is not safe to become pregnant after endometrial ablation. Rare but potential risks include:
Resectr is a disposable device that removes polyps without needing to pull or tug them out. It replaces common tissue removal tools such as graspers and forceps.
While you may not need to know the name of this device, it is important to be informed about polyps and how they contribute to AUB. Physicians who use Resectr are able to see and remove polyps in one office visit. To know if polyps are causing your symptoms, ask your physician about having a hysteroscopy. Click here to learn more about polyps.
Your physician will send the removed polyp tissue to be examined by a pathology lab. You will go about your day as normal, but may experience some spotting. Any cramping may be treated with over-the-counter pain medicine.
Physicians appreciate the efficient and elegant design of Resectr and feel it’s gentler for the patient. They are able to remove an entire polyp, which is beneficial for pathology analysis (because it is whole and not shredded or cut into pieces). Convenience may be the optimal benefit for both physician and patient. The ability to receive this treatment in the gynecologist's office may save time and money. And for ease and comfort, most patients prefer to be in the office rather than in a surgery center or hospital.
Minerva treatments for AUB are covered by most insurance providers. Talk to your physician about specific insurance options and offerings.
Pregnancy following an endometrial ablation is NOT SAFE and can be dangerous for the woman and fetus. Endometrial ablation is not a sterilization procedure, so speak with your physician about birth control options if needed.
While the likelihood of pregnancy is significantly decreased after endometrial ablation, you can still become pregnant. DO NOT have an endometrial ablation if you want to become pregnant.
